Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track focuses on the latest research in behavioral pharmacology, exploring how drugs influence behavior and mental processes. It aims to bridge the gap between pharmacological science and psychological outcomes.
This session will highlight cutting-edge developments in biomedicine and medical pharmacology, emphasizing therapeutic strategies and drug development. Participants will discuss the implications of these advancements for clinical practice.
This track will delve into the role of bioinformatics and biotechnology in enhancing pharmaceutical research and development. It will cover computational tools and methodologies that drive innovation in drug discovery.
This session will address the principles of biopharmaceutics and the pharmacokinetics of drug disposition. Discussions will focus on how these factors influence drug efficacy and safety in various populations.
This track will explore the latest research in cardiovascular pharmacology, including novel drug therapies and mechanisms of action. Experts will discuss the challenges and opportunities in treating cardiovascular diseases.
This session will examine the evolving role of clinical and hospital pharmacy in patient care. It will focus on best practices, medication management, and interdisciplinary collaboration in healthcare settings.
This track will highlight advancements in computational chemistry and its application in molecular drug design. Participants will discuss how these techniques are revolutionizing the drug development process.
This session will focus on the discovery and development of drugs derived from natural sources. It will explore the pharmacological potential of these compounds and their role in modern medicine.
This track will cover the pharmacological aspects of endocrine systems and their therapeutic implications. Participants will discuss the latest research on hormonal therapies and endocrine disorders.
This session will explore the intersection of neuropharmacology and pain management strategies. It will address current challenges and innovations in the treatment of pain through pharmacological interventions.
This track will focus on the methodologies and technologies used in pharmaceutical analysis and quality assurance. Discussions will emphasize the importance of maintaining high standards in drug development and manufacturing.